Free. Unsubscribe any time.
Kymera Therapeutics, Inc. (KYMR)
Kymera Therapeutics, Inc. filed 46 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 9 reporting owners, covering 241 transactions and 2,887,731 shares. 36 carry the SEC's AFF10B5ONE flag; 10 name a plan only in a footnote. 9 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-07-07, came 5 days after the one before it (2026-07-02) and reports 4 transactions against 14 in the filing before it.
- The sales it reports total 50,000 shares, 26,650 fewer than the 76,650 in the filing before it.
- Its 46 plan statements rank 117th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 2 have more plan statements on file than it and 8 have fewer.
- Its 46 filings on file run from 2025-06-03 to 2026-07-07, and state 2 plan adoption dates, from 2025-12-11 to 2025-12-16.
Trades in Kymera Therapeutics, Inc. 241
- Albers Jeffrey W. — 2025-06-03 · S · 6,349 shares
- Esposito Pamela — 2025-06-03 · S · 5,000 shares
- Mainolfi Nello — 2025-06-03 · S · 30,000 shares
- Ridloff Elena — 2025-06-03 · S · 7,200 shares
- Ridloff Elena — 2025-06-03 · S · 4,800 shares
- Ridloff Elena — 2025-06-11 · S · 4,500 shares
- Mainolfi Nello — 2025-09-16 · S · 30,000 shares
- Jacobs Bruce N. — 2025-09-17 · S · 79,220 shares
- Albers Jeffrey W. — 2025-10-13 · S · 5,000 shares
- Gollob Jared — 2025-10-13 · S · 3,114 shares
- Gollob Jared — 2025-10-15 · S · 29,264 shares
- Gollob Jared — 2025-10-15 · S · 8,963 shares
Adoption dates in Kymera Therapeutics, Inc. 2
- 2025-12-11 — stated in 1 filing
- 2025-12-16 — stated in 3 filings
Results prints in Kymera Therapeutics, Inc. 9
- 2025-01-14
- 2025-02-27
- 2025-05-09
- 2025-08-11
- 2025-11-04
- 2026-01-13
- 2026-02-26
- 2026-04-30
- 2026-08-05
Trades before a print in Kymera Therapeutics, Inc. 8
- 1 day before the 2026-02-26 print — 2026-02-25 · S · Mainolfi Nello · 19,764 shares
- 1 day before the 2026-02-26 print — 2026-02-25 · S · Mainolfi Nello · 5,434 shares
- 1 day before the 2026-02-26 print — 2026-02-25 · S · Mainolfi Nello · 3,293 shares
- 1 day before the 2026-02-26 print — 2026-02-25 · S · Mainolfi Nello · 1,501 shares
- 1 day before the 2026-02-26 print — 2026-02-25 · S · Mainolfi Nello · 8 shares
- 1 day before the 2026-04-30 print — 2026-04-29 · S · Mainolfi Nello · 17,005 shares
- 1 day before the 2026-04-30 print — 2026-04-29 · S · Mainolfi Nello · 12,059 shares
- 1 day before the 2026-04-30 print — 2026-04-29 · S · Mainolfi Nello · 936 shares
- 6 days before the 2025-11-04 print — 2025-10-29 · S · Mainolfi Nello · 1,862 shares
- 6 days before the 2025-11-04 print — 2025-10-29 · S · Mainolfi Nello · 24,511 shares
- 6 days before the 2025-11-04 print — 2025-10-29 · S · Mainolfi Nello · 3,627 shares
- 6 days before the 2026-02-26 print — 2026-02-20 · S · Esposito Pamela · 1,900 shares
Interval to Kymera Therapeutics, Inc.’s next reported results date
How the interval and sources are counted →
- 8within 5 days
- 17within 10 days
- 1shortest, days
- 0no later print
- Mainolfi Nello 2025-10-29 · S · 6 days before the 2025-11-04 print · Chief Executive Officer
- Mainolfi Nello 2025-10-29 · S · 6 days before the 2025-11-04 print · Chief Executive Officer
- Mainolfi Nello 2025-10-29 · S · 6 days before the 2025-11-04 print · Chief Executive Officer
- Esposito Pamela 2026-02-20 · S · 6 days before the 2026-02-26 print
- Esposito Pamela 2026-02-20 · S · 6 days before the 2026-02-26 print
- Mainolfi Nello 2026-02-25 · S · 1 day before the 2026-02-26 print · Chief Executive Officer
- Mainolfi Nello 2026-02-25 · S · 1 day before the 2026-02-26 print · Chief Executive Officer
- Mainolfi Nello 2026-02-25 · S · 1 day before the 2026-02-26 print · Chief Executive Officer
- Mainolfi Nello 2026-02-25 · S · 1 day before the 2026-02-26 print · Chief Executive Officer
- Mainolfi Nello 2026-02-25 · S · 1 day before the 2026-02-26 print · Chief Executive Officer
- Booth Bruce 2026-04-22 · S · 8 days before the 2026-04-30 print
- Booth Bruce 2026-04-22 · S · 8 days before the 2026-04-30 print
- Booth Bruce 2026-04-22 · S · 8 days before the 2026-04-30 print
- Chadwick Jeremy G 2026-04-22 · S · 8 days before the 2026-04-30 print · Chief Operating Officer
- Mainolfi Nello 2026-04-29 · S · 1 day before the 2026-04-30 print · Chief Executive Officer
- Mainolfi Nello 2026-04-29 · S · 1 day before the 2026-04-30 print · Chief Executive Officer
- Mainolfi Nello 2026-04-29 · S · 1 day before the 2026-04-30 print · Chief Executive Officer
Adoption dates Kymera Therapeutics, Inc. states
- 2025-12-11 in 1 filing
- 2025-12-16 in 3 filings
Filing text: “10b5-1 trading plan adopted by the Reporting Person on December 11, 2025”
Reported results dates on file
- 2025-01-14
- 2025-02-27
- 2025-05-09
- 2025-08-11
- 2025-11-04
- 2026-01-13
- 2026-02-26
- 2026-04-30
- 2026-08-05
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.